Events

This activity is designed to update neurosurgeons, neurologists, spine surgeons, physician assistants, nurse practitioners, residents, fellows, and any other healthcare provider who treats neurologic, cranial, and spinal disorders. The 2-day conference will feature didactic lectures, case discussions, and expert opinion dialogue covering the entire spectrum of neurosurgery including the latest on brain tumors, cerebrovascular, spine, peripheral nerve, trauma, functional, and pediatric neurosurgery. The latest advances and most up-to-date practice advances will be discussed and presented.

Program Overview Columbia University Medical Center invites you to join the leading educators from Columbia University, addressing an overview of high-yield challenging scenarios in managing C3G and Immune Complex MPGN disease. The half-day conference course is designed to enhance the knowledge of healthcare professionals on pathogenesis, genetics, pathology, and genetic variants associated with C3G disease. Through lectures and case-based presentations, this course will deliver up-to-date and cutting-edge information that can be directly integrated into clinical practice.  The course is tailored for healthcare providers specializing in Nephrology and addressing these issues and includes talks, Q&A, and panel discussions.   Learning Objectives Describe the distinct mechanisms underlying C3G and IC-MPGN, focusing on how complement dysregulation and immune complex deposition lead to these diseases. Identify genetic and acquired disruptions in complement regulation and their impact on glomerular function in C3G and IC-MPGN Discuss recent therapeutic advances targeting complement dysregulation, like iptacopan and pegcetacoplan, and their potential in modifying disease progression. Differentiate primary IC-MPGN from secondary forms associated with systemic diseases, and identify diagnostic criteria for distinguishing these subtypes Recognize the specific biopsy findings, complement assays, and genetic tests that aid in diagnosing C3G and IC GN. Discuss the prevalence, risk factors, and demographic characteristics associated with C3G and IC-MPGN.

Speaker: Faye Feller, MD, Executive Vice President, Chief Medical Officer, Geron Pharmaceuticals Location:  Herbert Irving Comprehensive Cancer Center, 1130 St. Nicholas Ave., New York, NY 10032 Room/Area: 1st floor auditorium Hosted by Teresa Palomero, PhD, Professor of Pathology and Cell Biology (in the Institute for Cancer Genetics) at CUMC This event is sponsored by the Herbert Irving Comprehensive Cancer Center's (HICCC) Edward P. Evans Center for Myelodysplastic Syndromes (MDS) at Columbia University, established to foster an all-encompassing approach in studying MDS giving us molecular, cellular genetic and epigenetic insights to develop and test innovative therapies.

Title TBD Speaker TBD     Lecture 12:00-1:00 pm Join via Zoom: https://forms.gle/8LiztVWjDieN12jh8